IPP Bureau
PIB: Pharmaceutical industry in Maharashtra
By IPP Bureau - August 03, 2022
The total financial outlay of the scheme is Rs.500 crore for a period of five years from 2021-22 to 2025-26.
PIB: Pharma companies manufacturing generic medicine
By IPP Bureau - August 03, 2022
Under the PMBJP, till 30.06.2022, 8742 PMBJKs have been opened across the country including Government Hospitals and Government premises.
PIB: India imported Rs. 35,249 crore worth APIs and Bulk drugs in 2021-22.
By IPP Bureau - August 03, 2022
India exported Bulk Drugs/Drug Intermediates worth Rs. 33,320 crore in financial year 2021-22.
Jubilant Pharmova gets 6 observations from USFDA for its facility at Roorkee
By IPP Bureau - August 03, 2022
he US FDA has issued six observations pursuant to the completion of the audit.
USFDA issues 3 observations for Aurobindo Pharma’s Unit XI
By IPP Bureau - August 03, 2022
The company has responded to the warning letter and carried out the committed corrections.
Sun Pharma Chairman Israel Makov to retire on completion of term
By IPP Bureau - August 03, 2022
He was appointed a Board member and the Chairman in 2012.
Strides receives USFDA approval for Cyclosporine Softgel Capsules
By IPP Bureau - August 03, 2022
Strides is the first Indian company to get approval for the product.
Cadila launches generic sitagliptin versions to treat uncontrolled type 2 diabetes
By IPP Bureau - August 02, 2022
The two generic drugs have been launched under the brand names Jankey & Sitenali.
Health Minister Mandaviya addresses inaugural ceremony of training programme for senior administrative medical officers of CGHS
By IPP Bureau - August 02, 2022
Health resources – both human and material are precious assets to the society and a robust health care administration and management system ensures their effective utilization: Dr Bharati Pravin Pawar
Thyrocare Technologies posts Q1FY23 consolidated PAT at Rs. 21.73 Cr
By IPP Bureau - August 02, 2022
The company has reported total income of Rs. 128.79 crores during the period ended June 30, 2022.
Statement from Krsnaa Diagnostics on IT survey
By IPP Bureau - August 02, 2022
The news report stating Krsnaa Diagnostics has accepted Rs 100 crores of undisclosed income is incorrect and baseless.
BioIVT promotes Dr. Richard Haigh to CEO
By IPP Bureau - August 02, 2022
UBC acquires Examoto
By IPP Bureau - August 02, 2022
With this acquisition, UBC provides the most comprehensive REMS services and innovative risk mitigation solutions for the biopharmaceutical industry
Ayush Minister Sonowal inaugurates Ayush Building Complex in Navi Mumbai
By IPP Bureau - August 01, 2022
Steps afoot to make RRIH & RRIUM as a Centres of Excellence for Allergic Disorder and for Regimental Therapy respectively
Casper Pharma completed USFDA pre-approval inspection
By IPP Bureau - July 31, 2022
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
